We are live on
!
Find out more
NIM
NEOS Investment Management Portfolio holdings
AUM
$27.1B
1-Year Est. Return
57.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.25B
AUM Growth
+$935M
(+28%)
Cap. Flow
+$872M
Cap. Flow
% of AUM
20.54%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$78.8M |
| 2 |
Apple
AAPL
|
+$66.5M |
| 3 |
NVIDIA
NVDA
|
+$55.9M |
| 4 |
Microsoft
MSFT
|
+$53.9M |
| 5 |
Amazon
AMZN
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
+$17.1M |
| 2 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$17.1M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$3.06M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$2.53M |
| 5 |
Insulet
PODD
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.68% |
| 2 | Consumer Discretionary | 10.52% |
| 3 | Healthcare | 10.01% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Labcorp
LH
$26.2B
| $222K | 0.01% |
966
-7
| -0.7% | -$1.61K |
|
577
Everest Group
EG
$14.5B
| $218K | 0.01% |
601
-4
| -0.7% | -$1.5K |
|
578
Packaging Corp of America
PKG
$21B
| $217K | 0.01% |
966
-7
| -0.7% | -$1.62K |
|
579
Scholar Rock
SRRK
$6.09B
| $209K | ﹤0.01% |
+4,836
| New | +$157K |
|
580
F5
FFIV
$23.8B
| $208K | ﹤0.01% |
+827
| New | +$198K |
|
581
Jazz Pharmaceuticals
JAZZ
$15.8B
| $206K | ﹤0.01% |
+1,672
| New | +$197K |
|
582
Domino's
DPZ
$10.1B
| $203K | ﹤0.01% |
484
-3
| -0.6% | -$1.31K |
|
583
IDEX
IEX
$16.4B
| $202K | ﹤0.01% |
965
-7
| -0.7% | -$1.53K |
|
584
Align Technology
ALGN
$10.8B
| $201K | ﹤0.01% |
965
-7
| -0.7% | -$1.56K |
|
585
Acadia Pharmaceuticals
ACAD
$4.68B
| $194K | ﹤0.01% |
10,596
| – | – |
|
586
Voyager Therapeutics
VYGR
$187M
| $84.8K | ﹤0.01% |
14,960
| – | – |
|
|
TALK
587
DELISTED
Talkspace
TALK
| $81.4K | ﹤0.01% |
26,337
| – | – |
|
588
Alector
ALEC
$223M
| $27.1K | ﹤0.01% |
14,344
| – | – |
|
589
American Airlines Group
AAL
$8.63B
| – | – |
-28,312
| Closed | -$318K |
|
590
Arcturus Therapeutics
ARCT
$449M
| – | – |
-24,481
| Closed | -$568K |
|
591
Avery Dennison
AVY
$13.2B
| – | – |
-972
| Closed | -$215K |
|
592
Axsome Therapeutics
AXSM
$11.1B
| – | – |
-2,327
| Closed | -$209K |
|
593
Bath & Body Works
BBWI
$3.49B
| – | – |
-8,652
| Closed | -$276K |
|
|
BCYC
594
Bicycle Therapeutics
BCYC
$258M
| – | – |
-17,652
| Closed | -$399K |
|
595
BioNTech
BNTX
$24.3B
| – | – |
-2,067
| Closed | -$245K |
|
596
Corbus Pharmaceuticals
CRBP
$141M
| – | – |
-25,486
| Closed | -$526K |
|
597
Denali Therapeutics
DNLI
$3.23B
| – | – |
-21,648
| Closed | -$631K |
|
598
Edgewise Therapeutics
EWTX
$4.85B
| – | – |
-23,359
| Closed | -$623K |
|
599
Jasper Therapeutics
JSPR
$19.5M
| – | – |
-11,219
| Closed | -$211K |
|
600
Oscar Health
OSCR
$9.89B
| – | – |
-43,854
| Closed | -$930K |
|
Similar funds
RG
LP
RCMU
SC
SO
NEOS Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, NEOS Investment Management held 613 positions worth $4.25B, up 28% from $3.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
NEOS Investment Management deployed $872M of net new capital in Q4 2024, opening 34 new positions and adding to 490 existing holdings. Its largest new stake was Palantir: 258,157 shares worth $19.5M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Insulet, an estimated $1.27M trimmed.
- NEOS Investment Management's largest Q4 2024 buy was Palantir: 258,157 shares worth $19.5M.
- NEOS Investment Management added most to Vanguard Russell 2000 ETF in Q4 2024, an estimated $78.8M increase.
- NEOS Investment Management's biggest Q4 2024 reduction was Insulet, cutting an estimated $1.27M.
- NEOS Investment Management fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q4 2024, selling an estimated $17.1M.
- NEOS Investment Management's ten largest holdings make up 38% of its $4.25B portfolio in Q4 2024.
- NEOS Investment Management opened 34 new positions and closed 25 in Q4 2024.
- NEOS Investment Management's portfolio value rose 28% quarter-over-quarter to $4.25B.
Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.